Peer Review History: Colon Cancer with Complete Pathological Response to Only 1 Cycle of Capecitabine: Treatment Modification in the Perspective of COVID-19 Pandemic

Editor(s):

(1) Dr. Sivapatham Sundaresan, SRM Medical College Hospital And Research Centre, SRM Institute of Science and Technology, India.

(2) Dr. Erich Cosmi, University of Padua School of Medicine, Italy.

(3) Dr. Rafik Karaman, College of Pharmacy, Al-Quds University, Palestine.

Reviewers:

(1) Riju Menon, Amrita Institute of Medical Sciences, India.

(2) Edmund Ui-Hang Sim, Universiti Malaysia Sarawak, Malaysia.

(3) R. Jasmine Bishop Heber College, India.

(4) P. Suresh Babu, India.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Riju Menon, India) | File 1 | File 2


Stage 2 | Peer review report_2 (Edmund Ui-Hang Sim, Malaysia) | File 1 | NA


Stage 2 | Peer review report_3 (R. Jasmine, India) | File 1 | NA


Stage 2 | Peer review report_4 (P. Suresh Babu, India) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Stage 3 | Comment_Editor_3_v1 | File 1 | NA